Enzymatic vitreolysis

Current Diabetes Reviews

Volumn 5, Issue 1, 2009, Pages 57-62

  Lopez Lopez, Fernando ^a   Rodriguez Blanco, Maria ^a   Gómez Ulla, Francisco ^a,b   Marticonera, Joaquin ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Technological Institute of Ophthalmology   (Spain)

Author keywords

Diabetic macular edema; Diabetic retinopathy; Microplasmin; Plasmin; Posterior vitreous detachment

Indexed keywords

FIBRINOLYTIC AGENT; HYALURONIDASE; MICROPLASMIN; N ACETYLGALACTOSAMINE 4 SULFATASE; PLASMIN; PLASMINOGEN; PLASMINOGEN[LYSINE]; STREPTOKINASE; SULFUR HEXAFLUORIDE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE; HYALURONOGLUCOSAMINIDASE; PEPTIDE FRAGMENT;

CLINICAL TRIAL; DIABETIC MACULAR EDEMA; DIABETIC PATIENT; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG SAFETY; DRUG THERAPY; ENZYMATIC VITREOLYSIS; HUMAN; IRITIS; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA DISEASE; REVIEW; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; VITRECTOMY; VITREOUS BODY DETACHMENT; METHODOLOGY; RETINA MACULA EDEMA;

DIABETIC RETINOPATHY; FIBRINOLYTIC AGENTS; HUMANS; HYALURONOGLUCOSAMINIDASE; MACULAR EDEMA; PEPTIDE FRAGMENTS; PLASMIN; VITRECTOMY; VITREOUS DETACHMENT;

EID: 65549165049     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339909787314220     Document Type: Review

References (66)

1. Marmor MF. Mechanisms of normal retinal adhesion. In: Wilkinson CP, Ed. Retina, Fourth ed. Philadelphia: Elsevier Inc., 2006; v. 3.
2. Maurice DM, Salmon J, Zauberman H. Subretinal pressure and retinal adhesion. Exp Eye Res 1971; 12: 212-7.
3. Marmor MF, Yao XY, Hageman GS. Retinal adhesiveness in surgically enucleated human eyes. Retina 1994; 14: 181-6.
4. Tsuboi S. Measurement of the volume flow and hydraulic conductivity across the isolated dog retinal pigment epithelium. Invest Ophthalmol Vis Sci 1987; 28: 1776-82.
5. Cantrill HL, Pederson JE. Experimental retinal detachment. VI. The permeability of the blood-retinal barrier. Arch Ophthalmol 1984; 102: 747-51.
6. Pederson JE, Cantrill HL. Experimental retinal detachment. V. Fluid movement through the retinal hole. Arch Ophthalmol 1984; 102: 136-9.
7. Hamann S, Kiilgaard JF, la Cour M, et al. Cotransport of H+, lactate, and H2O in porcine retinal pigment epithelial cells. Exp Eye Res 2003; 76: 493-504.
8. Nasrallah FP, Jalkh AE, Van Coppenolle F, et al. The role of the vitreous in diabetic macular edema. Ophthalmology 1988; 95: 1335-9.
9. Hikichi T, Fujio N, Akiba J, et al. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 1997; 104: 473-8.
10. Yamaguchi Y, Otani T, Kishi S. Resolution of diabetic cystoid macular edema associated with spontaneous vitreofoveal separation. Am J Ophthalmol 2003; 135: 116-8.
11. Watanabe M, Oshima Y, Emi K. Optical cross-sectional observation of resolved diabetic macular edema associated with vitreomacular separation. Am J Ophthalmol 2000; 129: 264-7.
12. Harbour JW, Smiddy WE, Flynn HW, Jr., Rubsamen PE. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996; 121: 405-13.
13. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992; 99: 753-9.
14. Pendergast SD, Hassan TS, Williams GA, et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 2000; 130: 178-86.
15. Rasquin F, Demols P, Vanheesbeke A, Schrooyen M. Vitrectomy for diabetic macular edema associated with hyaloid posterior traction. Bull Soc Belge Ophtalmol 2000; 276: 43-8.
16. van Effenterre G, Guyot-Argenton C, Guiberteau B, et al. Macular edema caused by contraction of the posterior hyaloid in diabetic retinopathy. Surgical treatment of a series of 22 cases. J Fr Ophtalmol 1993; 16: 602-10.
17. Ikeda T, Sato K, Katano T, Hayashi Y. Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br J Ophthalmol 1999; 83: 12-4.
18. Ikeda T, Sato K, Katano T, Hayashi Y. Attached posterior hyaloid membrane and the pathogenesis of honeycombed cystoid macular edema in patients with diabetes. Am J Ophthalmol 1999; 127: 478-9.
19. Tachi N. Surgical management of macular edema. Semin Ophthalmol 1998; 13: 20-30.
20. La Heij EC, Hendrikse F, Kessels AG, Derhaag PJ. Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol 2001; 239: 264-70.
21. Wu L. Edema macular diabético. In: Alfaro V, Quiroz-Mercado H, Gomez-Ulla F, et al, Eds. Retinopatía Diabética. Tratado Médico Quirurgico. Barcelona: Mac Line, S.L., 2006.
22. Gottlieb JL, Antoszyk AN, Hatchell DL, Saloupis P. The safety of intravitreal hyaluronidase. A clinical and histologic study. Invest Ophthalmol Vis Sci 1990; 31: 2345-52.
23. Wang ZL, Zhang X, Xu X, et al. PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy. Retina 2005; 25: 38-43.
24. Kuppermann BD, Thomas EL, de Smet MD, Grillone LR. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 2005; 140: 585-97.
25. Kuppermann BD, Thomas EL, de Smet MD, Grillone LR. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 2005; 140: 573-84.
26. Liotta LA, Goldfarb RH, Brundage R, et al. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 1981; 41: 4629-36.
27. Kohno T, Sorgente N, Ishibashi T, et al. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci 1987; 28: 506-14.
28. Russell SR, Shepherd JD, Hageman GS. Distribution of glycoconjugates in the human retinal internal limiting membrane. Invest Ophthalmol Vis Sci 1991; 32: 1986-95.
29. Verstraeten TC, Chapman C, Hartzer M, et al. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol 1993; 111: 849-54.
30. Li X, Shi X, Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol 2002; 240: 56-62.
31. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology 2000; 107: 1607-11.
32. Hikichi T, Yanagiya N, Kado M, et al. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina 1999; 19: 55-8.
33. Gandorfer A, Putz E, Welge-Lussen U, et al. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol 2001; 85: 6-10.
34. Williams JG, Trese MT, Williams GA, Hartzer MK. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology 2001; 108: 1902-5.
35. Le Mer Y, Korobelnik JF, Morel C, et al. TPA-assisted vitrectomy for proliferative diabetic retinopathy: results of a double-masked, multicenter trial. Retina 1999; 19: 378-82.
36. Hesse L, Nebeling B, Schroeder B, et al. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy. Exp Eye Res 2000; 70: 31-9.
37. Unal M, Peyman GA. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment. Retina 2000; 20: 69-75.
38. Gandorfer A, Ulbig M, Kampik A. Plasmin-assisted vitrectomy eliminates cortical vitreous remnants. Eye 2002; 16: 95-7.
39. Asami T, Terasaki H, Kachi S, et al. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema. Ophthalmology 2004; 111: 231-7.
40. Azzolini C, D'Angelo A, Maestranzi G, et al. Intrasurgical plasmin enzyme in diabetic macular edema. Am J Ophthalmol 2004; 138: 560-6.
41. Sakuma T, Tanaka M, Inoue J, et al. Use of autologous plasmin during vitrectomy for diabetic maculopathy. Eur J Ophthalmol 2006; 16: 138-40.
42. Hirata A, Takano A, Inomata Y, et al. Plasmin-assisted vitrectomy for management of proliferative membrane in proliferative diabetic retinopathy: a pilot study. Retina 2007; 27: 1074-8.
43. Diaz-Llopis M, Udaondo P, Garcia-Delpech S, et al. [Enzymatic vitrectomy by intravitreal autologous plasmin injection, as initial treatment for diffuse diabetic macular edema]. Arch Soc Esp Oftalmol 2008; 83: 77-84.
44. Udaondo P, Diaz-Llopis M, Garcia-Delpech S, et al. Autologous plasmin for intravitreal injection without associated vitrectomy: a simple preparation method with streptokinase. Arch Soc Esp Oftalmol 2008; 83: 153-4.
45. Diaz-Llopis M, Udaondo P, Salom D, et al. Intravitreal autologous plasmin without associated-vitrectomy. Pharmacological vitreolysis, a perfeccionated method using urokinase. Arch Soc Esp Oftalmol 2008; 83: 291-2.
46. Gandorfer A, Priglinger S, Schebitz K, et al. Vitreoretinal morphology of plasmin-treated human eyes. Am J Ophthalmol 2002; 133: 156-9.
47. Wang F, Wang Z, Sun X, et al. Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis. Invest Ophthalmol Vis Sci 2004; 45: 3286-90.
48. Margherio AR, Margherio RR, Hartzer M, et al. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology 1998; 105: 1617-20.
49. Chow DR, Williams GA, Trese MT, et al. Successful closure of traumatic macular holes. Retina 1999; 19: 405-9.
50. Whitefleet-Smith J, Rosen E, McLinden J, et al. Expression of human plasminogen cDNA in a baculovirus vector-infected insect cell system. Arch Biochem Biophys 1989; 271: 390-9.
51. Hrach CJ, Johnson MW, Hassan AS, et al. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes. Arch Ophthalmol 2000; 118: 659-63.
52. Johnson MW, Olsen KR, Hernandez E, et al. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 1990; 108: 259-63.
53. El Baha SM, Abou-Nazel MW, Idriss HF, Abdel-Megeed AS. The role of streptokinase in induction of posterior vitreous detachment: a scanning and transmission electron microscopic study of the retina in rabbits. Retina 2003; 23: 698-704.
54. Qu J, Li X, Huang B. Production of recombinant human microplasminogen and pilot study in inducing posterior vitreous detachment. Curr Eye Res 2005; 30: 881-9.
55. Chen W, Huang X, Ma XW, et al. Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator. Eye 2008; 22: 300-7.
56. Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci 2004; 45: 641-7.
57. Sakuma T, Tanaka M, Mizota A, et al. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Invest Ophthalmol Vis Sci 2005; 46: 3295-9.
58. Hikichi T, Kado M, Yoshida A. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit. Retina 2000; 20: 195-8.
59. Hermel M, Mahgoub M, Youssef T, et al. Safety profile of the intravitreal streptokinase-plasmin complex as an adjunct to vitrectomy in the rabbit. Graefes Arch Clin Exp Ophthalmol 2006; 244: 996-1002.
60. Men G, Peyman GA, Genaidy M, et al. The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment. Retina 2004; 24: 199-209.
61. Moorhead LC, Redburn DA, Kirkpatrick DS, Kretzer F. Bacterial collagenase. Proposed adjunct to vitrectomy with membranectomy. Arch Ophthalmol 1980; 98: 1829-39.
62. O'Neill R, Shea M. The effects of bacterial collagenase in rabbit vitreous. Can J Ophthalmol 1973; 8: 366-70.
63. Tezel TH, Del Priore LV, Kaplan HJ. Posterior vitreous detachment with dispase. Retina 1998; 18: 7-15.
64. Jorge R, Oyamaguchi EK, Cardillo JA, et al. Intravitreal injection of dispase causes retinal hemorrhages in rabbit and human eyes. Curr Eye Res 2003; 26: 107-12.
65. Staubach F, Nober V, Janknecht P. Enzyme-assisted vitrectomy in enucleated pig eyes: a comparison of hyaluronidase, chondroitinase, and plasmin. Curr Eye Res 2004; 29: 261-8.
66. Takano A, Hirata A, Ogasawara K, et al. Posterior vitreous detachment induced by nattokinase (subtilisin NAT): a novel enzyme for pharmacologic vitreolysis. Invest Ophthalmol Vis Sci 2006; 47: 2075-9.